Home / World Marketplace / Archive by category Global Health & Biotech (Page 44)

Archive by category Global Health & Biotech

Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)

REYKJAVIK, Iceland and PARSIPPANY, N.J., Feb. 18, 2025 (Korea Bizwire) – Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) [...]

Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US

MANAMA, Kingdom of Bahrain, Feb. 16, 2025 (Korea Bizwire) – The Bahrain Oncology Centre (BOC) has made medical history by successfully treating a sickle cell disease (SCD) patient using CRISPR-based gene-editing therapy, Casgevy (exagamglogene autotemcel). This marks the first successful treatment of its kind outside the United States, positioning Bahrain as a global leader in [...]

Zymeworks To Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on March 5, 2025

VANCOUVER, British Columbia, Feb. 13, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will report its fourth quarter and full year 2024 financial results [...]

Carestream Makes Contribution to Scholarship Program with New Corporate Partner American Society of Radiologic Technologists (ASRT)

Rochester, New York, Feb. 10, 2025 (Korea Bizwire) – Carestream is proud to announce a new corporate partnership with the American Society of Radiologic Technologists (ASRT), as well as an educational grant contribution to the latter’s ASRT Foundation, which will be applied toward ASRT scholarships and grants for CY 2025. This new partnership will [...]

Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis

Topline data from FIBRONEER™-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in forced vital capacity [mL] at week 52 versus placebo The FIBRONEER™-ILD trial is the second Phase III trial in which the investigational compound nerandomilast has met its primary endpoint1 Initial safety and tolerability [...]

Philips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patients

February 10, 2025 Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke treatment network Amsterdam, the Netherlands and Kyiv, Ukraine – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, in collaboration with the [...]

Essential Pharma and Clinigen Expand Collaboration to Improve Patient Access in JAPAC

Agreement drives continued patient access to four important therapies in Japan and Korea Strengthens Essential Pharma and Clinigen’s combined market presence in the JAPAC region Egham, UK – 6th February 2025 – Essential Pharma (“Essential” or “the Company”), an international specialty pharma group focused on ensuring that patients have access to low volume, clinically differentiated, niche [...]

Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases

- Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function- -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025- -Topline results from pivotal Phase 3 Trial in Immunoglobulin G4-Related Disease (INDIGO) expected year-end 2025- - Enrollment of Phase [...]

OPEN Health Appoints David Sakadelis as Chief Technology Officer

London, Feb. 05, 2025 (Korea Bizwire) – OPEN Health is pleased to announce the appointment of David Sakadelis as Chief Technology Officer. In this role, David will be responsible for enhancing our services through technology-enabled solutions for biopharma partners, focusing on solving challenges and driving innovation in our Solution Innovation Center. OPEN Health’s Solution Innovation Center (SIC) [...]

Beltone Debuts Latest Hearing Innovations with Beltone Envision(TM) Hearing Aids –The World’s Best Technology for Hearing in Noise And New Auracast Assistant

Designed with intelligent hearing technology, Beltone Envision AI powered hearing aids are compact yet powerful, helping individuals with hearing loss focus on hearing what matters most, even in challenging listening situations BALLERUP, Denmark, Feb. 04, 2025 (Korea Bizwire) – Beltone proudly introduces its latest innovation: Beltone Envision™ hearing aids. Featuring the world’s best technology for hearing in noise1, Beltone [...]